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Introduction {#sec001}
============

Ischemic neuropathy is common among patients with lower extremity peripheral artery disease \[[@pone.0237156.ref001],[@pone.0237156.ref002]\]. The incidence of critical limb ischemia caused by peripheral artery disease has been estimated to be approximately 500--1000 per million per year \[[@pone.0237156.ref003]--[@pone.0237156.ref006]\]. Clinical neurological deficits have been reported to occur in 22--88% of critical limb ischemia cases \[[@pone.0237156.ref007]\]. Sensory symptoms, such as numbness, painful paresthesia and burning \[[@pone.0237156.ref008],[@pone.0237156.ref009]\], may last for a long time in spite of reestablishing an adequate blood flow \[[@pone.0237156.ref010],[@pone.0237156.ref011]\]. The incidence of ischemic neuropathy may be expected to increase in line with the current and projected increases in the elderly and obese populations. However, effective therapies for ischemic neuropathy are not established.

Gene transfer via retrograde axonal transport is a possible way of expressing identified transgenes at targeted locations within the nervous system. Although the molecular mechanism of retrograde transport of HGF is not fully understood, we have achieved successful gene transfer into the rat peripheral nerves via retrograde axonal transport from intramuscular injections with either (a) with hemagglutinating virus of Japan (HVJ)-liposomes containing plasmids encoded with luciferase or ß-galactosidase, or (b) with HVJ envelope encoded with hepatocyte growth factor (HGF) \[[@pone.0237156.ref012],[@pone.0237156.ref013]\].

HGF, which was initially purified from rat serum \[[@pone.0237156.ref014],[@pone.0237156.ref015]\], has powerful neurotrophic and angiogenic effects \[[@pone.0237156.ref016]--[@pone.0237156.ref021]\]. Within the nervous system, HGF is trophic for peripheral sensory and motor neurons and enhances axonal outgrowth \[[@pone.0237156.ref016],[@pone.0237156.ref022]--[@pone.0237156.ref028]\]. We have demonstrated effective control of neuropathic pain by repeated intramuscular injections of human HGF in rat models of CCI \[[@pone.0237156.ref029]\] which was confirmed later \[[@pone.0237156.ref030]\]. HGF is also a powerful growth factor of endothelial cells and has been investigated for the treatment of ischemic diseases \[[@pone.0237156.ref019],[@pone.0237156.ref031]\]. Therapeutic angiogenesis with HGF has been reported in patients with critical limb ischemia \[[@pone.0237156.ref032]--[@pone.0237156.ref035]\].

In the search for an agent to improve the symptoms of ischemic neuropathy, HGF is a potent candidate because of its powerful neurotrophic and angiogenic properties. We have investigated whether nonviral retrograde gene transfer of HGF might improve ischemic neuropathy using the rat model of ischemic-reperfusion nerve injury (IRI).

Materials and methods {#sec002}
=====================

Rats {#sec003}
----

All animal procedures were carried out in compliance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of the National Defense Medical College (Protocol Number: 07021). One hundred-eight male Wistar rats, weighing 220--280 g, age 8--9 weeks were analyzed in this study. Animals were housed in a temperature-controlled room with a 12-hour light-dark cycle. During the procedure, all efforts were made to minimize suffering, to minimize the number of animals, to utilize alternative techniques, if available, to relieve pain and /or distress as necessary, and to increase the level of monitoring if rats exhibit the sign of morbidity. Rats were euthanized by CO~2~ inhalation followed by cervical dislocation.

Study design {#sec004}
------------

The method used to induce IRI was as described by Nukada and McMorran \[[@pone.0237156.ref036]\]. Briefly, in rats under sodium pentobarbital anesthesia the major arteries supplying the right hindlimb; abdominal aorta, common iliac, femoral, and superficial circumflex iliac arteries, were exposed and occluded for 4 h using microvascular clips (TKS- 1, 40g; Bear Medic Corporation, Ichikawa, Japan), and then reperfused.

Immediately after reperfusion, HVJ envelopes (100 μl) containing 100 μg human HGF plasmid DNA, were injected into the proximal one-third of the tibialis anterior muscle of the right hindlimb over a few minutes via a 27-gauge needle. HGF gene transfer was repeated at 1, 2 and 3 weeks after IRI. Rats were divided randomly into 4 groups as follows: (1) IRI with HGF gene transfer (IRI+HGF group), (2) IRI without HGF gene transfer (IRI group), (3) similar surgery to expose arteries but no IRI (sham group), and (4) no surgical procedures (control group).

Construction of plasmid DNA and preparation of the HVJ envelope-complex vector {#sec005}
------------------------------------------------------------------------------

To produce an HGF expression vector, human HGF cDNA (2.2 kb) was inserted between the NotI sites of a pcDNA 3.1 (−) vector. The HVJ envelope-complex vector was prepared using an HVJ envelope vector kit (GenomOne-Neo; Ishihara Sangyo, Osaka, Japan) as described previously \[[@pone.0237156.ref013]\].

In our previous studies, we have demonstrated that HGF expression in ipsilateral sciatic nerve and dorsal root ganglia (DRG) was high on day 3 and decline on Day 7 after the first gene transfer, and was high again day 3 after the second gene transfer \[[@pone.0237156.ref029]\]. We have also confirmed the specific primers we used against rat HGF mRNA did not cross-react with human HGF mRNA \[[@pone.0237156.ref029]\].

Behavioral studies {#sec006}
------------------

Mechanical allodynia and thermal hyperalgesia of the right hind paw were measured at 14 defined time-points until 8 weeks post-operation (1, 2, 3, 5, 7, 10, 14, 17, 21, 24 days, and 4, 5, 6, 7 weeks). Methods have been reported previously \[[@pone.0237156.ref029],[@pone.0237156.ref037],[@pone.0237156.ref038]\]. In brief, mechanical allodynia was determined by quantifying the withdrawal threshold of the soles of right hind paw in response to Von Frey hairs. Von Frey hairs were applied perpendicularly to the plantar surface of the hind paw, sufficient force being used to bend the filament. Brisk withdrawal or paw flinching was taken as a positive response.

Thermal hyperalgesia was assessed using a Hargreaves apparatus (Plantar Test; Ugo Basile, Italy). A radiant heat stimulus was applied to the midplantar area of the hind paw, and the time between initial heat and paw withdrawal was recorded. Each testing for mechanical allodynia and thermal hyperalgesia was repeated five times, and the mean value was used.

Laser Doppler flux and thermographic studies of the hind paw {#sec007}
------------------------------------------------------------

Blood flow and thermographic measurements in the hind paw were measured at baseline and 1, 3, 6 and 8 weeks after IRI, as in our previous study \[[@pone.0237156.ref029]\]. Blood flow was using a laser Doppler flowmeter (PIM II: Perimed AB, Järfälli, Sweden), and thermographic measurements was performed using a TH9100 ML camera (NEC Sanei, Tokyo, Japan).

Neurometer measurement of current stimulus threshold {#sec008}
----------------------------------------------------

The stimulus thresholds were measured using a Neurometer according to the method of Kiso et al. \[[@pone.0237156.ref039]\]. Briefly, a small electrode (GT100-30; Neurotron Inc., Baltimore, USA) for stimulation was attached to the plantar surface of the hind paw. A skin patch dispersion electrode (TE174D; Fukuda Denshi, Tokyo, Japan) was attached to the lower back of the rat. In rats lightly restrained using Ballman cages (Natsume, Tokyo, Japan), transcutaneous nerve stimuli---each comprising three sine-wave pulses at 5, 250, or 2,000 Hz---were applied to the plantar surface, using an animal response test mode of the Neurometer Current Perception Threshold (CPT) (Neurotron Inc., Baltimore, MD) \[[@pone.0237156.ref040]\]. Delivery of sinusoidal electrical stimuli at 5, 250, or 2,000 Hz allows evaluation of responses primarily in small unmyelinated (C), small myelinated (Aδ), and large myelinated (Aβ) fibers, respectively \[[@pone.0237156.ref041]--[@pone.0237156.ref045]\]. The minimum current intensity (mA) at which each rat vocalized was defined as the CPT. The data presented herein were obtained from three consecutive measurements, and the CRT was measured before surgery and at 1, 3, 6 and 8 weeks after surgery.

Nerve conduction study {#sec009}
----------------------

Rat was on a heating pad, and the right hindlimb skin temperature was kept 35 ± 1ºC. The right sciatic nerve was exposed from the sciatic notch to the knee under general anesthesia with sodium pentobarbital. The nerve was stimulated using hook electrodes at the sciatic notch and knee. Recording needle electrodes were placed in the 1st and 4th interosseus muscles of the foot. Motor nerve conduction velocity (MNCV) and compound motor action potential (CMAP) were recorded using Neuropack instrumentation (Nihon Koden, Tokyo, Japan) as described previously \[[@pone.0237156.ref046]\]. Nerve conduction studies of the right sciatic nerve were carried out before surgery, and at 1, 3, 6, and 8 weeks after surgery.

Histological studies of the sciatic nerve {#sec010}
-----------------------------------------

After measurements of MNCV and CMAP at 3, 6 and 8 weeks post-surgery, bilateral sciatic and tibial nerves were taken from the upper-thigh to ankle level under sodium pentobarbital anesthesia (n = 6 at each time-point for each group) \[[@pone.0237156.ref036]\]. All specimens were fixed overnight in 2.5% glutaraldehyde in 0.1 M phosphate buffer solution (pH 7.4). Subsequently, they were postfixed with 1% osmium tetroxide, dehydrated, and cut into consecutive 2--3 mm blocks before embedding in epoxy resin. Semi-thin sections (1 μm in thickness) were stained with methylene blue. Ultra-thin sections were stained with EM stainer followed by lead citrate and examined with a transmission electron microscope (H7600, Hitachi, Tokyo, Japan). Morphometric analysis of the number and diameter of myelinated nerve fibers and the number of endoneurial microvessels in sciatic and tibial nerves, was determined using a NIH image analysis.

RT-PCR {#sec011}
------

The mRNA expressions for P2X2, P2X3, and P2X4 receptors, and TRPV1 (transient receptor potential vanilloid receptor subtype 1) in right sciatic nerve, right DRG (L5), and spinal cord were examined at 1 and 3 weeks post-operatively by semiquantitative RT-PCR as described previously \[[@pone.0237156.ref029]\]. Sequence information used in the current study is listed in [S1 Table](#pone.0237156.s001){ref-type="supplementary-material"}.

Statistical analysis {#sec012}
--------------------

Values for each parameter are expressed as means ± SD. Fisher\'s protected least-significant-difference test was applied to the data when significant F-ratios were obtained in an analysis of variance (ANOVA), and significance was set at *p*\<0.05. The statistical significance of the difference between curves representing repeated measures of behavioral function (allodynia or hyperalgesia) was assessed using a repeated measures analysis (SPSS Inc., Chicago, IL, USA).

Results {#sec013}
=======

Mechanical and thermal thresholds {#sec014}
---------------------------------

On day 1 post-surgery, right hind paw withdrawal threshold using Von Frey hairs in both IRI+HGF and IRI groups was significantly decreased when compared with pre-surgical levels, and was also significantly less than in control and sham groups ([Fig 1A](#pone.0237156.g001){ref-type="fig"}). The mechanical threshold in IRI+HGF group became significantly greater than in IRI group on week 1 post-surgery, and thereafter increased with time ([Fig 1A](#pone.0237156.g001){ref-type="fig"}). The recovery of threshold in IRI+HGF group was faster than in IRI group, and at week 5 post-surgery, threshold in IRI+HGF group became not significantly different from those in controls. The mechanical threshold of left hind paw in IRI+HGF and IRI groups was reduced, although statistically not significant. Raw data of these thresholds of bilateral hind paws in IRI+HGF, IRI, control and sham groups were shown in [S2 Table](#pone.0237156.s002){ref-type="supplementary-material"}.

![Behavioral studies: Mechanical allodynia and thermal hyperalgesia.\
Time-course data for tactile-response threshold using Von Frey hairs **(A)** and withdrawal latency to infrared heat stimulus **(B)** of the right hind paw in IRI (○ broken line), IRI+HGF (■ solid line), and control (◊ dotted line) groups. Data are expressed as mean ± SD (n = 12 for each group at each time point). \**p* \< 0.01: IRI+HGF *vs*. IRI.](pone.0237156.g001){#pone.0237156.g001}

Thermal threshold was significantly reduced at day 1 post-surgery in both IRI and IRI+HGF groups when compared with those in control and sham groups ([Fig 1B](#pone.0237156.g001){ref-type="fig"}). However, the recovery of threshold was much faster in IRI+HGF group than in IRI group. At week 2 post-surgery, there was no significant differences of thresholds between IRI+HGF group and controls. Thermal threshold in IRI+HGF group was significantly greater from week 2 to 6 post-surgery than in IRI group ([Fig 1B](#pone.0237156.g001){ref-type="fig"}). There were no significant changes of behavioral studies in the control and sham groups.

Laser Doppler flux and thermographic studies {#sec015}
--------------------------------------------

Laser Doppler flux of the right hind paw in IRI+HGF group was not significantly different at all time-points from those in controls. Blood flow in IRI group was significantly decreased at weeks 1 and 3 post-surgery than those in IRI+HGF group ([Fig 2](#pone.0237156.g002){ref-type="fig"}). Blood flow in the left hind paw was not significantly different between experimental groups ([Fig 2](#pone.0237156.g002){ref-type="fig"}).

![Skin blood flow by laser Doppler flux.\
Time-course data for laser Doppler flux of right and left hind paws in IRI (open bars) and IRI+HGF (solid bars) groups. Pre (fine checkered bars): pre-surgery. I/R (coarse checkered bars): during ischemic-reperfusion surgery. Data are expressed as mean ± SD (n = 6 for each group at each time point). \**p* \< 0.01: IRI+HGF *vs*. IRI.](pone.0237156.g002){#pone.0237156.g002}

Skin temperature of the right hind paw in IRI+HGF group was significantly greater than in IRI group at weeks 1, 3, and 6 post-surgery, although it was reduced in both IRI+HGF and IRI groups when compared with pre-surgical levels ([Fig 3](#pone.0237156.g003){ref-type="fig"}). Skin temperature in the left hind paw of both IRI+HGF and IRI groups was significantly reduced at week 1 when compared with pre-surgical level ([Fig 3](#pone.0237156.g003){ref-type="fig"}). In control and sham groups, there were no significant changes of blood flow and thermographic measurements.

![Skin temperature by thermographic measurements.\
Time-course data for thermographic skin temperature of right and left hind paws in IRI (open bars) and IRI+HGF (solid bars) groups. Pre (fine checkered bars): pre-surgery. I/R: (coarse checkered bars) during ischemic-reperfusion surgery. Data are expressed as mean ± SD (n = 6 for each group at each time point). \**p* \< 0.01: IRI+HGF *vs*. IRI.](pone.0237156.g003){#pone.0237156.g003}

Neurometer measurement of current stimulus threshold {#sec016}
----------------------------------------------------

Regardless of whether stimuli were delivered at 5, 250, or 2,000 Hz, the threshold at the right hind paw was significantly reduced in both IRI+HGF and IRI groups when compared with pre-surgical level. However, the threshold in IRI+HGF group was significantly greater than in IRI group at 1, 3, 6 and 8 post-surgery ([Fig 4](#pone.0237156.g004){ref-type="fig"}). In the left hind paw, thresholds at all current stimuli were lowered in both IRI+HGF and IRI groups at 1 week post-surgery, and at 2,000 Hz stimulus, thresholds in IRI+HGF group were significantly greater than in IRI group at weeks 1 and 3 ([S1 Fig](#pone.0237156.s005){ref-type="supplementary-material"}). In control and sham groups, no significant changes have been observed.

![Neurometer current perception threshold.\
Neurometer measurements of stimulus threshold at 5 **(A)**, 250 **(B)** and 2,000 **(C**) Hz to the plantar surface of the right hind paw in IRI (open bars) and IRI+HGF (solid bars) groups, and pre-surgical levels (Pre OP, checkered bars). Data are expressed as mean ± SD (n = 6 for each group at each time point). \**p* \< 0.01: IRI+HGF *vs*. IRI.](pone.0237156.g004){#pone.0237156.g004}

Nerve conduction study {#sec017}
----------------------

MNCVs and CMAP of the right sciatic nerves were significantly reduced in both IRI+HGF and IRI groups when compared with pre-surgical levels ([Fig 5](#pone.0237156.g005){ref-type="fig"}). However, MNCVs in IRI+HGF group were significantly faster than in IRI group at weeks 3 and 6 post-surgery ([Fig 5A](#pone.0237156.g005){ref-type="fig"}). CMAPs amplitude in IRI+HGF group was significantly greater than in IRI group ([Fig 5B](#pone.0237156.g005){ref-type="fig"}) at week 3. Recovery of slowed MNCVs and lowered CMAP amplitudes were faster in IRI+HGF group than in IRI group, correlated with the recovery of foot and toe drop.

![Nerve conduction studies of sciatic nerves.\
MNCV **(A)** and CMAP **(B)** of the right sciatic nerve in IRI (open bars) and IRI+HGF (solid bars) groups, and pre-surgical levels (Pre OP, checkered bars). Data are expressed as mean ± SD (n = 6 for each group at each time point). \**p* \< 0.01: IRI+HGF *vs*. IRI.](pone.0237156.g005){#pone.0237156.g005}

Histological study of the sciatic nerve {#sec018}
---------------------------------------

Semi-thin transverse sections at the lower-thigh level of right sciatic nerve obtained at week 3 post-surgery revealed a loss of large myelinated nerve fibers in both IRI+HGF and IRI groups, although the number of large myelinated nerve fibers was apparently greater in IRI+HGF group than in IRI group ([Fig 6](#pone.0237156.g006){ref-type="fig"}). Small myelinated nerve fibers observed in both groups were mainly regenerating nerve fibers. Nerve fibers with disproportionately thin myelin relative to axon area were observed ([S2 Fig](#pone.0237156.s006){ref-type="supplementary-material"}), suggesting regenerating nerve fibers. Nerve fibers with axonal degeneration were scattered in both IRI and IRI+HGF groups, although more prominent in IRI group ([Fig 6](#pone.0237156.g006){ref-type="fig"}). Unmyelinated nerve fibers were apparently normal under the electron microscopy ([S2 Fig](#pone.0237156.s006){ref-type="supplementary-material"}). Endoneurial edema and vascular changes were not apparent.

![Histological evaluation of sciatic nerves.\
Semi-thin transverse sections at the lower thigh level of the right sciatic nerve at 3 weeks post-surgery in sham (A), IRI (B) and IRI+HGF (C) groups. A loss of large myelinated nerve fibers and the presence of small myelinated nerve fibers were prominent in both IRI and IRI+HGF groups. Nerve fibers with axonal degeneration (arrows) were more noticeable in IRI group when compared with IRI+HGF group. \*perineurium. Bars = 20μm.](pone.0237156.g006){#pone.0237156.g006}

Morphometric analysis of myelinated nerve fibers at the lower-thigh level of right sciatic nerve at 3weeks after surgery revealed that the number of myelinated nerve fibers, and mean diameter and area of myelinated nerve axons were significantly less in both IRI+HGF and IRI groups than in controls ([Table 1](#pone.0237156.t001){ref-type="table"}). However, axon area and diameter were significantly greater in IRI+HGF group that in IRI group ([Table 1](#pone.0237156.t001){ref-type="table"}). The diameter histogram of myelinated nerve fibers confirmed an increased number of small myelinated nerve fibers in both IRI+HHGF and IRI groups ([S3 Fig](#pone.0237156.s007){ref-type="supplementary-material"}). Peaks of axon diameters in both groups occurred at around 1.5μm, while the peak of controls was approximately 3.5μm.

10.1371/journal.pone.0237156.t001

###### Morphometric parameters of myelinated nerve fibers at the lower-thigh level of right sciatic nerve at 3 weeks after ischemic-reperfusion injury.

![](pone.0237156.t001){#pone.0237156.t001g}

                                                  IRI+HGF       IRI           control        *p*[\*](#t001fn002){ref-type="table-fn"}
  ----------------------------------------------- ------------- ------------- -------------- ------------------------------------------
  Number of myelinated nerve fibers               1153 ± 109    1143 ± 86     1986 ± 155     *0*.*34*
  Axon diameter of myelinated nerve fibers (μm)   2.01 ± 0.04   1.79 ± 0.01   3.16 ± 0.17    *0*.*0063*
  Axon area of myelinated nerve fibers (μm^2^)    5.05 ± 0.21   3.99 ± 0.14   11.51 ± 1.10   *0*.*0036*

Data are means ± SD

\* IRI+HGF vs. IRI.

In sciatic nerves at the lower-thigh level, fascicular area at 3 weeks after surgery was not significantly between experimental groups ([Fig 7](#pone.0237156.g007){ref-type="fig"} and [S3 Table](#pone.0237156.s003){ref-type="supplementary-material"}). The density of endoneruial microvessels in both right and left sciatic nerves was significantly greater in IRI+HGF than in IRI, sham and control groups ([Fig 7](#pone.0237156.g007){ref-type="fig"}, [S4 Fig](#pone.0237156.s004){ref-type="supplementary-material"} and [S3 Table](#pone.0237156.s003){ref-type="supplementary-material"}). Transverse semi-thin sections of the contralateral (left) sciatic nerves at the upper-thigh level in IRI+HGF and IRI groups were showed in [S5 Fig](#pone.0237156.s009){ref-type="supplementary-material"} to highlight a contrast of the number of endoneurial microvessels. A significant increased density of endoneruial microvessels in IRI+HGF group was observed in bilateral tibial nerves as well ([S6 Fig](#pone.0237156.s010){ref-type="supplementary-material"} and [S4 Table](#pone.0237156.s004){ref-type="supplementary-material"}).

![Morphometry of fascicular area and endoneurial microvessels.\
Fascicular area and the density of endoneurial microvessels at the lower-thigh level of bilateral sciatic nerves after 3 weeks post-surgery in IRI+HGF (solid bars), IRI (open bars), control (fine checkered bar) and sham (coarse checkered bar) groups. \**p* \< 0.01: IRI+HGF *vs*. IRI, control and sham.](pone.0237156.g007){#pone.0237156.g007}

RT-PCR {#sec019}
------

We detected mRNA expressions for P2X2, P2X3, P2X4, and P2Y1 receptors, and for TRPV1, in right sciatic nerve, right DRG (L5) and spinal cord at weeks 1 and 3 post-surgery. We calculated ratios for the expression levels of the various receptor mRNA to those of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA. In sciatic nerves, ratios obtained for P2X3 receptor mRNA, P2Y1 receptor mRNA, and TRPV1 mRNA in IRI group were all significantly greater than in IRI+HGF and control groups at week 1 ([Fig 8](#pone.0237156.g008){ref-type="fig"}). The ratios of P2X3 and P2Y1 mRNAs at week 3 were not significantly different between three groups. Ratios obtained for TRPV1 mRNA at weeks 1 and 3 in IRI+HGF group were significantly less when compared with those in IRI group, although were significantly greater than in control group ([Fig 8](#pone.0237156.g008){ref-type="fig"}). No significant differences were found among 3 groups in the ratios obtained for P2X2 receptor mRNA and P2X4 receptor mRNA ([Fig 8](#pone.0237156.g008){ref-type="fig"}). In DRG, the mRNA levels were measured by mixing together all the specimens from 6 rats at each time-point, because of the small size of rat DRG. The ratios obtained for P2X3 and P2Y1 receptors and TRPV1 mRNAs in DRG at weeks 1 and 3 showed a similar trend as those of sciatic nerves; lower ratios in IRI+HGF than in IRI group ([S7 Fig](#pone.0237156.s011){ref-type="supplementary-material"}). In spinal cord, the ratio for TRPV1 mRNA in IRI+HGF group was significantly less when compared with those in IRI group at weeks 1 and 3, although mRNA expressions of P2X2, P2X3, P2X4 and P2Y1 receptors were not significantly different between three groups ([Fig 8](#pone.0237156.g008){ref-type="fig"}).

![RT-PCR studies of sciatic nerves and spinal cord.\
mRNA expressions of P2X2, P2X3, P2X4, and P2Y1 receptors, and TRPV1 at weeks 1 and 3 post-surgery in IRI (open bars), IRI+HGF (solid bars), and control (checkered bars) groups. Data are expressed as mean ± SD (n = 6 for each group at each time point). \**p* \< 0.05: IRI vs. IRI+HGF and control. \*\*p\<0.05 IRI+HGF vs. IRI and control.](pone.0237156.g008){#pone.0237156.g008}

Discussion {#sec020}
==========

We have investigated whether nonviral retrograde gene transfer of HGF might improve symptoms of ischemic neuropathy using a rat model of IRI, and demonstrated that HGF gene transfer resulted in 1) significant improvement of mechanical allodynia and thermal hyperalgesia, decreased skin blood flow and temperature, lowered plantar thresholds of electrical stimuli in the hind paw, and sciatic nerve conduction parameters, 2) enhanced nerve regeneration in the sciatic nerve histologically, 3) significant increases of the density of endoneurial microvessels in bilateral sciatic and tibial nerves, and 4) reduction of the elevated levels of P2X3 and P2Y1 receptor mRNA and TRPV1 mRNA in the sciatic nerve. These results suggest that repeated retrograde gene transfer of HGF may improve symptoms of ischemic neuropathy.

Several well-defined underlying molecular mechanisms of retrograde transport of neurotrophic factors have been identified \[[@pone.0237156.ref047]\], and the efficacy of intramuscular injection over the calf muscle of HGF has been demonstrated. In our previous study, we demonstrated expression of human HGF-like immunoreactive protein in the rat sciatic nerve by repeated intramuscular injections of nonviral gene transfer of human HGF into the hindlimb muscle \[[@pone.0237156.ref029]\]. In fact, in the DRG and sciatic nerve at 3 days after the first and second HGF gene transfers, the levels of rat HGF mRNA and protein were increased 1.2- to 2.5-fold when compared with those in controls. We have also shown the efficacy of HGF upon neuropathic pain in a rat model of CCI \[[@pone.0237156.ref029]\]. Intramuscular injections of HGF have also been successful for treatment of models of streptozocin-induced diabetes \[[@pone.0237156.ref048]\] and crush injury \[[@pone.0237156.ref027]\]. Clinically, intramuscular administration of VM202, plasmid DNA expressing two isoforms of HGF, resulted in significant symptomatic relief in painful diabetic neuropathy \[[@pone.0237156.ref049]\]. In a double-blind, placebo-controlled study, Kessler at al. confirmed that repeated intramuscular injections of HGF are effective in reducing pain in patients with painful diabetic neuropathy \[[@pone.0237156.ref050]\].

There have been electrophysiological and histological studies of the ischemic neuropathy caused by IRI \[[@pone.0237156.ref036],[@pone.0237156.ref051]--[@pone.0237156.ref053]\]. However, the mechanism causing sensory symptoms, e.g. numbness, paresthesia, burning and pain, is still not completely understood. In this study, we confirmed that mechanical allodynia and thermal hyperalgesia were evident within 1 day after IRI and persisted for at least 6 weeks. Repeated HGF gene transfer was successful in enhanced recover of these mechanical allodynia and thermal hyperalgesia after IRI. Using an animal response test mode of the Neurometer CPT, we also found that all nerve fibers including small unmyelinated (C), small myelinated (Aδ), and large myelinated (Aβ) fibers, were adversely affected after IRI and repeated HGF gene transfer led to an early full recovery to the pre-surgical level in all three fiber types.

By analyzing the morphometrical parameters of endoneurial microvessels and myelinated nerve fibers in sciatic nerves at 3 weeks after surgery, we found that 1) the number of endoneurial microvessels was significantly increased in IRI+HGF group than in IRI, control and sham groups, and 2) axon area and diameter of myelinated nerve fibers in IRI+HGF group were significantly greater when compared with those in IRI group. Neovascularization by HGF gene transfer enhanced nerve regeneration, and an increased axon area in IRI+HGF group was due to the presence of intensified regenerating nerve fibers. Because ischemia causes delayed nerve regeneration \[[@pone.0237156.ref054],[@pone.0237156.ref055]\], regenerating nerve fibers in IRI group were associated with a decrease in axon area.

A significant increased density of endoneurial vessels was observed in the contralateral sciatic and tibial nerves as well in IRI+HGF group. Because the transient ligation of abdominal aorta, at the level of distal to left iliolumbar artery and proximal to right illiolumar artery, during an ischemic surgery, transient ischemia at the mid-thigh level of sciatic nerve which is the watershed zone along the length of sciatic-tibial nerves \[[@pone.0237156.ref056],[@pone.0237156.ref057]\], occurred in the contralateral hind limb \[[@pone.0237156.ref036],[@pone.0237156.ref053]\]. Other results in the current study including behavioral studies, skin blood flow and temperature, and Neurometer measurements, also suggested mild ischemia in the contralateral side. Because s, the potent angiogenic property of HGF spread into the contralateral hind limb.

Levels of P2X3 and P2Y1 receptors, and TRPV1 mRNAs in sciatic nerves and DRG were elevated at 1 week after IRI, and these elevations were depressed by repeated HGF gene transfer. It is known that the P2X3 receptor is expressed by unmyelinated sensory nerve fibers and mediates thermal hyperalgesia, whereas P2Y1 receptors are expressed by myelinated sensory nerve fibers and mediate mechanical allodynia \[[@pone.0237156.ref058]--[@pone.0237156.ref060]\]. TRPV1 is essential for tissue injury-induced thermal hyperalgesia \[[@pone.0237156.ref061]\]. Our results suggest when HGF protein is induced via nonviral retrograde gene transfer, it may act directly on the nervous system to exert effects leading to improvements in mechanical and thermal thresholds \[[@pone.0237156.ref016],[@pone.0237156.ref022]--[@pone.0237156.ref025],[@pone.0237156.ref042]\]. Intriguingly, we failed to find increases in P2X2 or P2X4 mRNA levels after IRI. P2X2/3 heteromerics show a relation to mechanical allodynia induction \[[@pone.0237156.ref062]\]. Tsuda et al. reported that mechanical allodynia requires activation of the P2X4 receptor, and nerve injury-induced pain depends upon ongoing signaling via the P2X4 receptor \[[@pone.0237156.ref059]\]. Indeed, in our previous study using a rat model of CCI, we demonstrated preventive effect of repeated HGF gene transfer on an induction of mechanical allodynia and elevations in the levels of P2X2, P2X4, and P2Y1 receptor mRNAs \[[@pone.0237156.ref029]\].

Conclusion {#sec021}
==========

We have demonstrated that transfer of the human HGF gene into the rat nervous system by repeated intramuscular injection of HVJ envelope resulted in potent angiogenesis and subsequently enhanced nerve regeneration in ischemic nerves. These results support HGF transfer as a promising candidate for treatment of acute ischemic nerve injury caused by reperfusion injury.

Supporting information {#sec022}
======================

###### Primer sequences, TaqMan probe sequences, and thermocycle conditions used for RT-PCR.

(DOCX)

###### 

Click here for additional data file.

###### Raw data of withdrawal threshold (g) using Von Frey hairs of bilateral hind paws in IRI+HGF, IRI, control and sham groups.

(DOCX)

###### 

Click here for additional data file.

###### Morphometric data at the lower-thigh level of bilateral sciatic nerves at 3 weeks post-surgery: Fascicular area, and the density and total number of endoneurial microvessels in IRI+HGF, IRI, control and sham groups.

(DOCX)

###### 

Click here for additional data file.

###### Morphometric data at the lower-calf level of bilateral tibial nerves at 3 weeks post-surgery: Fascicular area, and the density of endoneurial microvessels in IRI+HGF, IRI, and control groups.

(DOCX)

###### 

Click here for additional data file.

###### 

Neurometer measurements of stimulus threshold at 5 **(A)**, 250 **(B)** and 2,000 **(C**) Hz to the plantar surface of the left hind paw in IRI (open bars) and IRI+HGF (solid bars) groups, and pre-surgical levels (Pre OP, checkered bars). Data are expressed as mean ± SD (n = 6 for each group at each time point). \**p* \< 0.01: IRI *vs*. IRI+HGF.

(TIF)

###### 

Click here for additional data file.

###### Electron micrograph at the lower-thigh level of right sciatic nerve at 3 weeks after surgery showing normal unmyelinated nerve fibers.

Note myelinated nerve fibers with disproportionally thin myelin relative to axon. area Bar = 2μm.

(TIF)

###### 

Click here for additional data file.

###### Histograms of axon diameter against axon numbers of myelinated nerve fibers at lower-thigh level of right sciatic nerves at 3 weeks post-surgery in IRI (dotted line), IRI+HGF (solid line), and control (broken line) groups.

(TIF)

###### 

Click here for additional data file.

###### The total number of endoneurial microvessels at the lower-thigh level of sciatic nerves 3 weeks after surgery in IRI+HGF (closed bars), IRI (open bars), control (checkered bar) and sham (dotted bar) groups.

\**p* \< 0.01: IRI+HGF *vs*. IRI.

(TIF)

###### 

Click here for additional data file.

###### 

Semi-thin transverse sections at the upper thigh level of the contralateral (left) sciatic nerves at 3 weeks post-surgery showing endoneurial microvessels (arrows) in IRI+HGF (A) and IRI (B) groups. The number of endoneurial microvessels in HGF-treated nerve (A) was apparently greater than in IRI nerve (B). Bars = 25μm. \*perineurium.

(TIF)

###### 

Click here for additional data file.

###### Fascicular area and the density of endineurial microvessels at the lower-calf level of bilateral tibial nerves 4 weeks after surgery in IRI+HGF (closed bars), IRI (open bars) and control (checkered bar) groups.

(TIF)

###### 

Click here for additional data file.

###### RT-PCR data of DGR: mRNA expressions of P2X2, P2X3, P2X4, and P2Y1 receptors, and TRPV1 at weeks 1 and 3 post-surgery in IRI (open bars), IRI+HGF (solid bars), and control (checkered bars) groups.

Data are expressed as mean ± SD (n = 6 for each group at each time point).

(TIF)

###### 

Click here for additional data file.

HGF

:   Hepatocyte growth factor

IRI

:   ischemic-reperfusion nerve injury

CMAP

:   compound muscle action potentials

MNCV

:   motor nerve conduction velocity

TRPV1

:   transient receptor potential vanilloid receptor subtype 1

HVJ

:   hemagglutinating virus of Japan

CPT

:   current perception threshold

ANOVA

:   analysis of variance

GAPDH

:   glyceraldehyde 3-phosphate dehydrogenase

DRG

:   dorsal root ganglia

CCI

:   chronic constriction injury

10.1371/journal.pone.0237156.r001
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PONE-D-20-09804

Efficacy of nonviral gene transfer of human hepatocyte growth factor (HGF) against ischemic-reperfusion nerve injury in rats

PLOS ONE

Dear Dr. Nukada,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jun 08 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Soroku Yagihashi, MD, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

The submitted paper was sent to the external reviewers specialized in this field. Both reviewers admitted the value of this study worthy publication. However, they also pointed out several issues that should be carefully attended to before the acceptance for publication.

From the handling editor, some additional issues are suggested for the improvement of the content.

1\. The mechanism of how HGF worked for the correction of ischemia/reperfusion injury is not still clear. Confirmation of HGF transfer to peripheral nervous system was not well evaluated. Thus, the statement in the text should be toned down.

2\. Regarding the above issue, the authors evaluated only ipsilateral side of surgical procedure. There is no statement on the changes of contralateral side, nor any statement on the effects of HGF on this side. If there occurs some improvement in rats with HGF treatment in opposite side, correction of vascular impairement may be implicated for the improvement.

3\. Morphometry of endoneurial as well as epineurial vasculature may be worth for the improvement of content referring implication of endoneurial edema and its improvement by HGF.

4\. Evidence of promoted nerve fiber regeneration in HGF-treatment group is obscure. Pictures provided are not sufficient for recognition of degenerated or regenerated fibers. There appears to be endoneurial edema which should be evaluated by morphometry. Was it possible to consider that the data of fiber (axonal) atrophy in ischemic neuropathy were rescued by HGF?

5\. Figure 1; IRI+HGF should be open square, not closed

6\. Angiogenetic should be angiogenic.

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1.    Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf> and <http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information on the animal research and ensure you have included details on (1) methods of sacrifice, (2) methods of analgesia, and (3) efforts to alleviate suffering.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This is a detailed series of experiments employing behavioural, functional and morphometric and molecular techniques to evaluate the benefit of HGF gene transfer after ischemia reperfusion injury.

The experimental protocols and methods are appropriate.

The results are of interest and build on previously published data showing HGF efficacy in STZ diabetic neuropathy and in a small clinical trial of patients with painful neuropathy (Kessler et al Ann Clin Transl Neurol 2015; 2: 465-478).

However, I believe the translational value of this approach in ischemic neuropathy is potentially limited as patients often have long periods of chronic ischemia before an acute occlusion may develop.

The conclusion is focused on the beneficial effect of HGF on 'symptoms'

'resulted in a reducing effect on symptoms of ischemic neuropathy caused by IRI'.

However, apart from mechanical allodynia which is an indirect assessment of symptoms, no other symptoms have been evaluated in this model?

The pain is principally mediated by small fibres, yet the morphological examination has been undertaken in large myelinated fibres?

The effect on the vasculature which is the mechanism by which HGF is assumed to work has either not been quantified or is very qualitatively presented. Was there any change in endoneurial or epineurial vascular density or morphology (luminal size, endothelial cell number/area)?

Is motor function altered in these animals after IRI?

Why is MNCV slower in the IRI+HGF group?

Should myelinated nerve fibre regeneration not be associated with a decrease in axon and fibre areas due to the presence of regenerating fibres?

There is no morphological examination of the C-fibres, either with EM in the sciatic nerve or IENFD?

What was the effect on fascicular area as a measure of endoneurial oedema?

Is HGF angiogenetic or angiogenic?

Line 297 area not are

Reviewer \#2: Tsuchihara et al. reported the potential efficacy of non-viral human HGF gene transfer toward ischemic neuropathy in rats. In this study, HGF gene transfer alleviated mechanical allodynia and thermal hyperalgesia, and restored skin blood flow and temperature, neurometer current perception threshold, and motor nerve conduction velocity and compound action potential amplitude in rats with ischemic-reperfusion nerve injury (IRI). In addition, HGF gene transfer ameliorated the reduced axon diameter and area of myelinated nerve fibers and the up-regulation of P2X3 and TRPV1 receptor mRNA expression in sciatic nerves in IRI rats.

The authors employed various kinds of techniques to evaluate large and small nerve fiber function and morphometry in IRI rats. The manuscript is basically comprehensible, the purpose of the study is clear, and the findings are straightforward. Using the similar methodology, the authors demonstrated the efficacy of transient expression of HGF toward CCI and diabetic neuropathy in rats. In addition to those studies, the present study indicates usefulness of HGF gene transfer toward ischemic neuropathy. However, several drawbacks of this manuscript need to be pointed out.

1\. The authors failed to provide evidence of successful HGF gene transfer into IRI rats.

2\. The authors stated that there were no significant changes between the \[control\] and \[sham\] groups (Lines 196-197, 204-205, 210-211), but failed to provide data. They need to show the data as supplementary information.

3\. In Figs.1-4, no statistical analyses were performed between \[control\] and \[IRI\] or \[IRI+HGF\]. It is unclear why the authors did not use \[sham\] for comparison with \[IRI\] or \[IRI+HGF\].

4\. It is unclear which scale indicates 1-8 weeks in the horizontal axis of Fig.1A and B.

5\. A representative photomicrograph for \[control\] or \[sham\] should be added to Fig.5A. It is also important to indicate the effects of HGF gene transfer on the morphology of blood vessels and/or endothelial cells in IRI rats.

6\. In Fig.6, the authors conducted classical semiquantitative RT-PCR analysis; currently, real-time RT-PCR is a standard methodology. If the authors want to use these data, it would be recommended to show them as supplementary information and tone down the statement based on these findings.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Rayaz A Malik

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0237156.r002
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Additional Editor Comments (if provided):

1\. The mechanism of how HGF worked for the correction of ischemia/reperfusion injury is not still clear. Confirmation of HGF transfer to peripheral nervous system was not well evaluated. Thus, the statement in the text should be toned down.

The reviewer is correct. In the current study, we have not demonstrated the exact molecular mechanism of HGF on ischemic /reperfusion injury.

However, we have confirmed the HGF transfer into the PNS in our previous studies using exactly the same technique. New sentences have been added: Line 69-70, Line 293-307.

2\. Regarding the above issue, the authors evaluated only ipsilateral side of surgical procedure. There is no statement on the changes of contralateral side, nor any statement on the effects of HGF on this side. If there occurs some improvement in rats with HGF treatment in opposite side, correction of vascular impairment may be implicated for the improvement.

Data from the contralateral side was included.

Following sentences, figures and tables have been replaced or added:

Line 196-9, 210-1, 214-6, 222-5, 327-35.

Figs: 2, 3 & 7, S Figs: 1, 4, 5 & 6.

S Tables: 2, 3 & 4.

3\. Morphometry of endoneurial as well as epineurial vasculature may be worth for the improvement of content referring implication of endoneurial edema and its improvement by HGF.

Yes, we have added the morphometric analysis of endoneurial microvessels. In this study, all endoneurial vessels which diameter less than 30 μm were counted as microvessels.

Following sentences, figs and tables have been added:

Line 48, 50, 172, 253-60, 288-9, 319-21, Fig 7, S Figs 4, 5 & 6, and S Tables 3 & 4.

4\. Evidence of promoted nerve fiber regeneration in HGF-treatment group is obscure. Pictures provided are not sufficient for recognition of degenerated or regenerated fibers. There appears to be endoneurial edema which should be evaluated by morphometry. Was it possible to consider that the data of fiber (axonal) atrophy in ischemic neuropathy were rescued by HGF?

Fig 6 was revised.

An EM photo was added (S2 Fig).

Fascicular area was measured (Fig 7, S6 Fig, S Tables 3 & 4)).

5\. Figure 1; IRI+HGF should be open square, not closed

Fixed.

6\. Angiogenetic should be angiogenic.

Corrected..

Reviewer \#1: This is a detailed series of experiments employing behavioural, functional and morphometric and molecular techniques to evaluate the benefit of HGF gene transfer after ischemia reperfusion injury.

The experimental protocols and methods are appropriate.

The results are of interest and build on previously published data showing HGF efficacy in STZ diabetic neuropathy and in a small clinical trial of patients with painful neuropathy (Kessler et al Ann Clin Transl Neurol 2015; 2: 465-478).

Thanks so much. We have quoted the above paper by Kessler et al. 2015 (Line 305-7).

However, I believe the translational value of this approach in ischemic neuropathy is potentially limited as patients often have long periods of chronic ischemia before an acute occlusion may develop.

The conclusion is focused on the beneficial effect of HGF on 'symptoms'

'resulted in a reducing effect on symptoms of ischemic neuropathy caused by IRI'.

However, apart from mechanical allodynia which is an indirect assessment of symptoms, no other symptoms have been evaluated in this model?

The reviewer is correct. We have used the model of acute ischemia, and chronic ischemia is another story. The word 'acute' has been added (Line54 & 356).

We have also evaluated thermal and Neurometer thresholds, although not sensory symptoms. However, the word 'symptoms' has been deleted in the conclusion.

The pain is principally mediated by small fibres, yet the morphological examination has been undertaken in large myelinated fibres?

We have added a picture of unmyelinated nerve fibers (S2 Fig), and a new sentence (Line 242-3).

The effect on the vasculature which is the mechanism by which HGF is assumed to work has either not been quantified or is very qualitatively presented. Was there any change in endoneurial or epineurial vascular density or morphology (luminal size, endothelial cell number/area)?

Vascular morphometry of endoneurials has been added as mentioned above. There are no apparent abnormalities of vascular morphology (Line 243-4).

Is motor function altered in these animals after IRI?

Why is MNCV slower in the IRI+HGF group?

Yes, foot/toe drop has developed in ischemic limbs, and we have added a sentence (Line 233).

Even rats in HGF group showed nerve degeneration including large myelinated nerve fibers, but the recovery is significantly faster than non HGF-treated nerves. .

Should myelinated nerve fibre regeneration not be associated with a decrease in axon and fibre areas due to the presence of regenerating fibres?

Yes, we entirely agree with the reviewer. Morphometry was done after 3 weeks of surgery only in the current study. As the reviewer suggested, we added new sentences (Line 323-6).

There is no morphological examination of the C-fibres, either with EM in the sciatic nerve or IENFD?

We have added an EM photo of unmyelinated nerve fibers (S2 Fig).

What was the effect on fascicular area as a measure of endoneurial oedema?

We have added these data (Fig 7, S6 Fig, S Table 3 & 4))

Is HGF angiogenetic or angiogenic?

Angiogenic. Fixed.

Line 297 area not are

Corrected (now Line 321).

Reviewer \#2: Tsuchihara et al. reported the potential efficacy of non-viral human HGF gene transfer toward ischemic neuropathy in rats. In this study, HGF gene transfer alleviated mechanical allodynia and thermal hyperalgesia, and restored skin blood flow and temperature, neurometer current perception threshold, and motor nerve conduction velocity and compound action potential amplitude in rats with ischemic-reperfusion nerve injury (IRI). In addition, HGF gene transfer ameliorated the reduced axon diameter and area of myelinated nerve fibers and the up-regulation of P2X3 and TRPV1 receptor mRNA expression in sciatic nerves in IRI rats.

The authors employed various kinds of techniques to evaluate large and small nerve fiber function and morphometry in IRI rats. The manuscript is basically comprehensible, the purpose of the study is clear, and the findings are straightforward. Using the similar methodology, the authors demonstrated the efficacy of transient expression of HGF toward CCI and diabetic neuropathy in rats. In addition to those studies, the present study indicates usefulness of HGF gene transfer toward ischemic neuropathy. However, several drawbacks of this manuscript need to be pointed out.

1\. The authors failed to provide evidence of successful HGF gene transfer into IRI rats.

Please refer the comment 1 to the editor.

2\. The authors stated that there were no significant changes between the \[control\] and \[sham\] groups (Lines 196-197, 204-205, 210-211), but failed to provide data. They need to show the data as supplementary information.

Yes, we have added the data of sham group (Fig 7, S4 & 6 Figs , and S2, 3 & 4 Tables).

3\. In Figs.1-4, no statistical analyses were performed between \[control\] and \[IRI\] or \[IRI+HGF\]. It is unclear why the authors did not use \[sham\] for comparison with \[IRI\] or \[IRI+HGF\].

As mentioned in the text, there is no significant difference between control and sham groups. Because of the simplicity of figures, we have shown only three limes in Figs 1A & 1B.

Because focusing on the effect of HGF, we emphasized data of IRI+HGF and IRI groups.

4\. It is unclear which scale indicates 1-8 weeks in the horizontal axis of Fig.1A and B.

Figs 1A and 1B were revised.

5\. A representative photomicrograph for \[control\] or \[sham\] should be added to Fig.5A. It is also important to indicate the effects of HGF gene transfer on the morphology of blood vessels and/or endothelial cells in IRI rats.

A photo of sham group was added in Fig 6.

Morphometry of endoneurial microvessels was added as mentioned above.

6\. In Fig.6, the authors conducted classical semiquantitative RT-PCR analysis; currently, real-time RT-PCR is a standard methodology. If the authors want to use these data, it would be recommended to show them as supplementary information and tone down the statement based on these findings.

A part of Fig 8 (originally Fig 6) was moved to S7 Fig.

10.1371/journal.pone.0237156.r003
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PONE-D-20-09804R1

Dear Dr. Nukada,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Soroku Yagihashi, MD, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The authors well responded to the reviewers\' and my comments. The revised version has much been improved and well readable.

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: All my comments have been addressed and the authors have made changes to address my concerns.

Although the fact that unmyelinated nerve fibres and vessels are not abnormal does beg the question as to the underlying pathophysiology of this model.

Reviewer \#2: The manuscript has been revised in an appropriate way, and the authors provided additional data and figures. I have no further comments on it.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: **Yes: **Rayaz Malik

Reviewer \#2: No

10.1371/journal.pone.0237156.r004
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Efficacy of nonviral gene transfer of human hepatocyte growth factor (HGF) against ischemic-reperfusion nerve injury in rats

Dear Dr. Nukada:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Soroku Yagihashi

Academic Editor

PLOS ONE
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